Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT02433002
Eligibility Criteria:
Inclusion Criteria:
* Patients with stage 3 CKD (GFR 30-59 mL/min/1.73 m2) as defined internationally, diagnosed using MDRD/CKDEPI eGFR (at least two consecutive test results in this range at least 90 days apart, with the most recent test in the last 12 months)
* Aged 18 years or over
* Written informed consent
Exclusion Criteria:
* History of untoward reactions to iodinated contrast media or allergy to topical iodine
* Episode of acute kidney injury in previous 6 months (as defined by the Acute Kidney Injury Network criteria)
* Amputation of whole or part-limb
* Pregnant or breastfeeding
* Known current alcohol or drug abuse
* Kidney transplant recipient
* Any condition with an expected survival of less than study duration
* Inability to comply with study schedule and follow-up
* Inability to provide informed consent e.g. due to cognitive impairment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02433002
Study Brief:
Protocol Section:
NCT02433002